Navigation Links
Biodel Reports First Quarter Fiscal Year 2011 Financial Results
Date:2/3/2011

company's new drug application for Linjeta™; the company's response to the complete response letter; the importance of the complete response letter; and the company's focus, goals, strategy, research and development programs, and ability to develop and commercialize product candidates.  Forward-looking statements represent our management's judgment regarding future events.  All statements, other than statements of historical facts, including statements regarding our strategy, future operations, future clinical trial results, future financial position, future revenues, projected costs, prospects, plans and objectives of management are forward-looking statements.  The words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.  The company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to respond to the complete response letter regarding our new drug application for Linjeta™ in a timely manner and the possibility that information we provide in response to the letter may not be accepted by the FDA; our ability to secure FDA approval for Linjeta™ and our other product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel™ technology; the progress or success of our research, development and clinical programs and the initiation and completion of our clinical trials; the possibility that patients taking Li
'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
2. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
3. Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer
4. Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results
5. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
6. Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting
7. Biodel Awarded $1.2 Million in Therapeutic Discovery Research Grants From IRS
8. FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta™
9. Biodel to Present at Upcoming Conferences
10. Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
11. Biodel Appoints Arthur Urciuoli to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MOUNTAIN VIEW, Calif. , May 28, 2015  IRIDEX ... Officer and Chief Financial Officer James H. Mackaness ... Wednesday, June 3, 2015, at 9:00 am PT in ... webcast of the presentation may be accessed on the Event ... www.iridex.com .  A replay of the webcast will be available ...
(Date:5/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/pph6hl/united_states ... "United States Medical Adhesives Market Forecast and Opportunities, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , The market ... States is projected to register 9% ... manufacturers across the US are expanding their production ...
(Date:5/28/2015)... The Parenteral Drug Association (PDA) proudly ... of the Johnson & Johnson Kilmer Conference on ... Johnson & Johnson (J&J) is reviving the conference ... endoscopes. J&J ran 8 conferences on sterilization, validation ... on advances in sterilization and other topics. ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... VEGAS, June 27, 2011 Gamma Pharmaceuticals, Inc. (NASDAQ: ... own branded products through wholesalers and direct to retailers, ... Company has completed a sale and revenue collection cycle ... Company,s energy gel products to a Northeast distribution center ...
... Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today ... based on tumor reprogramming will be presented at the ... 14th World Conference on Lung Cancer meeting ( www.2011worldlungcancer.org ...   "The data presentations from both lung ...
Cached Medicine Technology:Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 2Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 3Syndax Pharmaceuticals Announces Entinostat Data from Two Lung Cancer Clinical Trials at Upcoming World Lung Conference 2Syndax Pharmaceuticals Announces Entinostat Data from Two Lung Cancer Clinical Trials at Upcoming World Lung Conference 3Syndax Pharmaceuticals Announces Entinostat Data from Two Lung Cancer Clinical Trials at Upcoming World Lung Conference 4
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe’s ... expertise to the Los Angeles County clinics including ... procedures are now being offered at all Healthpointe ... County, and San Bernardino County. , As ... neurons send electrical impulses throughout the body ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe is ... Joint Fluid Therapy (JFT) at their clinics in Orange ... injectable treatment that assists in diminishing pain for patients ... Dr. Stanley Katz and Dr. Neil Katz of Healthpointe. ... sodium hyaluronate (also known as hyaluronic acid) a natural ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 For the ... (USAU) to bring the Denver youth ultimate community an opportunity ... learning and individual improvement. The mission of the USAU Nike ... boys and girls to improve, build character, and make lifelong ... for boys and girls of all skill and ability levels, ...
(Date:5/29/2015)... News: 2015-2016 Oil Market Forecast, Company: Carson Energy, ... , In July, 2014, the price of oil ... US shale production and increased production from Saudi Arabia. ... from US shale producers, started producing close to their ... into the marketplace, they could push oil prices below ...
(Date:5/29/2015)... May 29, 2015 Wimbledon Health Partners, ... electrocardiogram (EKG), echocardiogram and NCV testing, is proud ... guidelines for EKG interpretation of athletes. ... of death during athletic activity. New findings presented in ... discussion to improve cardiac safety in athletes. Physiologic adaptations ...
Breaking Medicine News(10 mins):Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3
... Institute of Medicine recommends ways to avert an impending health care ... number of health care workers with the skills to meet their ... older by 2030 as the baby boom generation ages. The ... do to ensure that older Americans get the best care possible. ...
... 11 /Xinhua-PRNewswire-FirstCall/ -- Linkwell,Corporation (Linkwell) (OTC Bulletin ... of healthcare related disinfectants in China,announced today ... Hi-Tech Company, Ltd., (LiKang Disinfectant) was selected ... Ministry of Human Resources and,Social Security (MOHRSS) ...
... to evaluate palpable breast lesions, they can rule out ... conducted by researchers at Baystate Health in Springfield, MA. ... protocol. , We were interested in finding out ... together, in excluding breast cancer in women with palpable ...
... Registration is now,open for CleanMed 2008, ... practices and green building. The event is,produced ... Harm,along with partners Consorta, the Heinz Endowments, ... Center., CleanMed attracts major health care ...
... Set for June as Plan Moves Forward, HARRISBURG, ... provide input on Pennsylvania,s new State Plan on Aging., ... to help the,Department of Aging prioritize the needs and ... wellness and fitness programs, legal,assistance, and long-term living options. ...
... cancer patients who had an MRI examination before their initial ... out of Yale University School of Medicine. , ... treatment and 374 who did not undergo an MRI examination. ... Carol Lee, MD, an author of the study, now at ...
Cached Medicine News:Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 2Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 3Health News:Mammography plus sonography can help rule out breast cancer in patients with palpable lesions 2Health News:Creating Healing Environments: Healthcare Industry's Largest Sustainability Conference to be Held May 20-22 in Pittsburgh 2Health News:April 15 is Deadline for Input on State Aging Plan 2
... Rapid Toxin A Test gives your laboratory clear-cut ... it might be C. difficile, you can't afford ... a few tests a day or sends out ... Toxin A C. difficile Rapid Toxin A Test ...
... C. Diff A is a ... qualitative detection of Clostridium difficile ... , ,Clearview C. Diff A ... to provide fast, accurate detection ...
... come back with better resolution, accuracy and ... 25 or 31 rings (same as TMS-1), ... provides high accuracy & repeatability. The small ... & provides extensive corneal coverage. The low ...
... The OCULUS Pachycam is the first ... built-in keratometer. The OCULUS Pachycam ... (intra ocular pressure) in accordance with ... "real IOP. The OCULUS Pachycam ...
Medicine Products: